Increased Cerebrospinal Fluid Norepinephrine in Essential Hypertension

References

• Brosnihan K.B., Szilagyi J.E., Ferrario C.M. “Effect of Chronic Sodium Depletion on Cerebrospinal Fluid and Plasma Catecholamines,”. Hypertension 1981; 3: 233–239
   PubMed Web of Science ®Google Scholar
• Chalmers J.P., Reid J.L. “Participation of Central Noradrenergic Neurons in Arterial Baroreceptor Reflexes in the Rabbit,”. Circ. Res. 1972; 31: 789
   PubMed Web of Science ®Google Scholar
• Chalmers J.P., Dollery C.T., Lewis P.J., Reid J.L. “The Importance of Central Adrenergic Neurons in Renal Hypertension in Rabbits,”. J. Physiol. 1974; 238: 403
   PubMed Web of Science ®Google Scholar
• Davies D., Reid J.L. Central Action of Drugs in Blood Pressure. University Park Press, Baltimore 1975
   Google Scholar
• Davson H. Physiology of the Cerebrospinal Fluid. Little, Brown, Boston 1967
   Google Scholar
• Eide I., Kolloch R., DeQuattro V., Miano L., Dugger R. and Van der Meulen, J., “Raised Cerebrospinal Fluid Norepinephrine in Some Patients with Primary Hypertension,”. Hypertension 1979; 1: 255–259
   PubMed Web of Science ®Google Scholar
• Fuxe, et al, Davies D., Reid J. Central Action of Drugs in Blood Pressure Regulation. University Park Press, Baltimore 1978
   Google Scholar
• Lake C.R., Ziegler M.G., Kopin I.J. “Use of Plasma Norepinrphine for Evaluation of Sympathetic Neuronal Function in Man,”. Life Sci. 1976; 18: 1315–1326
   PubMed Web of Science ®Google Scholar
• Lake C.R., Gullner H.G., Polinski R.J., Ebert M.H., Ziegler M.G., Bartter F.C. “Essential Hypertension: Central and Peripheral Norepinephrine,”. Science 1981; 211: 955–957
   PubMed Web of Science ®Google Scholar
• Lindvall M., Edvinsson L., Owman C. “Histochemical, Ultrastructural and Functional Evidence for a Neurogenic Control of CSF Production from the Choroid Plexus,”. Advances in Neurology, J. Cervos-Navarro, et al. Raven Press, New York 1978; Vol. 20
   Google Scholar
• Lindvall M., Edvinsson L., Owman C. “Effect of Sympathomimetic Drugs and Corresponding Receptor Antagonists on the Rate of Cerebrospinal Fluid Production,”. Exp. Neurol. 1979; 64: 135–145
   Google Scholar
• Murray S., Jones D.H., Davies D.S., Dollery C.T., Reid J.L. “Free and Total 3-Methoxy-4-Hydroxyphenylethylene glycol in Human Cerebrospinal Fluid: Relationship to Blood Pressure in Hypertensives and Patients with Neuropsychiatric Disease,”. Clin. Chim. Acta 1977; 79: 63
   PubMed Web of Science ®Google Scholar
• Nathanson J.A. “β-Adrenergic-Sensitive Adenylate Cyclase in Secretory Cells of Choroid Plexus,”. Science 1979; 204: 843–844
   PubMed Web of Science ®Google Scholar
• Post R.M., Kotin J., Goodwin F.K., Gordon E.K. “Psychomotor Activity and Cerebrospinal Fluid Amine Metabolites in Affective Illness,”. Amer. J. Psychiatry 1973; 130: 67–72
   PubMed Web of Science ®Google Scholar
• Post R.M., Lake C.R., Jimerson D.C., Bunney W.E., Wood J.H., Ziegler M.G., Goodwin F.K. “Cerebrospinal Fluid Norepinephrine in Affective Illness,”. Am. J. Psychiatry 1978; 135: 907–912
   PubMed Web of Science ®Google Scholar
• Reid J.L., Jones D.H., Fitzgerald G., Davies D., Boobis A. “Catecholamine Turnover in Essential Hypertension,”. Clin. Exp. Hypertension 1980; 2: 395–408
   PubMed Web of Science ®Google Scholar
• Reid J.L., Zivin J.A., Kopin I.J. “Central and Peripheral Adrenergic Mechanisms in the Development of Deoxycorti-costerone-Saline Hypertension in Rats,”. Circ. Res. 1975; 37: 569
   PubMed Web of Science ®Google Scholar
• Saran R.K., Sahuja R., Gupta N.N., Hasan M., Bhargava K.P., Shanker K., Kishor D. “3–Methoxy-4–Hydroxyphenyl-glycol in Cerebrospinal Fluid and Vanillylmandelic Acid in Urine of Humans with Hypertension,”. Science 1978; 200: 317
   PubMed Web of Science ®Google Scholar
• Scriabine A., Clineschmidt B., Sweet C. Ann. Rev. Pharmacol. Toxicol. 1976; 16: 113
   PubMed Web of Science ®Google Scholar
• Sinha J.N., Deitl H., Philippu A. “Effect of a Fall of Blood Pressure on the Release of Catecholamines in the Hypothalamus,”. Life Sci. 1980; 26: 1751–1760
   PubMed Web of Science ®Google Scholar
• Teychenne P.F., Lake C.R., Ziegler M.G., Plotkin C., Wood J.H., Calne D.B. “Central and Peripheral Deficiency of Norepinephrine in Parkinson's Disease and the Effects of L-Dopa Therapy,”. Neuroscience 1977; 3: 47
   Google Scholar
• Teychenne P.F., Lake C.R., Ziegler M.G. “Cerebrospinal Fluid Studies in Parkinson's Disease: Norepinephrine and Gamma-Amino–butyric Acid Concentration,”. Neurobiology of Cerebrospinal Fluid, J.H. Wood. Plenum Publishing Corp. 1980; 197–204
   Google Scholar
• Veersteeg D.H.G., Palkovits M., Van Der Gugten J., Wijnin-Henk L.J.M., Smeets G.W.M., de Jong W. “Catecholamine Content of Individual Brain Regions of Spontaneously Hypertensive Rats,”. Brain Res. 1976; 112: 429
   PubMed Web of Science ®Google Scholar
• Westlund K.N., Bowker R.M., Ziegler M.G., Coulter J.D. “Origins of Spinal Noradrenergic Pathways Demonstrated by Retrograde Transport of Antibody to Dopamine-Beta-Hydroxylase,”. Neurosci. Lett. 1981; 25: 243–249
   PubMed Web of Science ®Google Scholar
• Ziegler M.G., Lake C.R., Kopin I.J. “Plasma Noradrenaline Increases With Age,”. Nature 1976; 261: 333–335
   PubMed Web of Science ®Google Scholar
• Ziegler M.G., Lake C.R., Kopin I.J. “Norepinephrine in Cerebrospinal Fluid,”. Brain Res. 1976; 108: 436–440
   PubMed Web of Science ®Google Scholar
• Ziegler M.G., Lake C.R., Wood J.H., Ebert M.H. “Circadian Rhythm in Cerebrospinal Noradrenaline of Man and Monkey,”. Nature 1976; 264: 656–658
   PubMed Web of Science ®Google Scholar
• Ziegler M.G., Lake C.R., Wood J.H., Brooks B.R., Ebert M.H. “Relationship Between Norepinephrine in Blood and Cerebrospinal Fluid in the Presence of a Blood-Cerebrospinal Fluid Barrier for Norepinephrine,”. J. Neurochem. 1976; 28: 677–679
   Google Scholar
• Ziegler M.G., Wood J.H., Lake C.R., Kopin I.J. “Norepinephrine and 3–Methoxy-4–Hydroxyphenylglycol Gradients in Human Cerebrospinal Fluid,”. Am. J. Psychiatry 1977; 134: 565–568
   PubMed Web of Science ®Google Scholar
• Ziegler M.G., Brooks B.R., Lake C.R., Wood J.H., Enna S.J. “Norepinephrine and γ-Amino-Butyric Acid in Amyotrophic Lateral Sclerosis,”. Neurology 1980; 3098–101
   Google Scholar
• Ziegler M.G., Lake C.R., Wood J.H., Ebert M.H. “Norepinephrine in Cerebrospinal Fluid: Basic Studies, Effects of Drugs and Disease,”. Neurobiology of Cerebrospinal Fluid, J.H. Wood. Plenum Publishing Corp. 1980; 141–149
   Google Scholar
• Ziegler M.G., Lake C.R., Wood J.H., Brookes B.R. “Relationship Between Cerebrospinal Fluid Norepinephrine and Blood Pressure in Neurologic Patients,”. Clin. Exp. Hypertension 1980; 2: 995–1008
   PubMed Web of Science ®Google Scholar
• Ziegler M.G., Lake C.R. Frontiers of Clinical Neuro-science: Norepinephrine. Williams and Wilkins Publishers, in press
   Google Scholar